INVIAPI Trademark

Trademark Overview

On Thursday, October 13, 2016, a trademark application was filed for INVIAPI with the United States Patent and Trademark Office. The USPTO has given the INVIAPI trademark a serial number of 79196626. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, April 25, 2025. This trademark is owned by Boehringer Ingelheim International GmbH. The INVIAPI trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the fields of respiratory diseases and oncology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

General Information

Serial Number79196626
Word MarkINVIAPI
Filing DateThursday, October 13, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, April 25, 2025
Registration Number5577712
Registration DateTuesday, October 9, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 24, 2018

Trademark Statements

Goods and ServicesMedical and scientific research in the fields of respiratory diseases and oncology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, April 25, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events

Event DateEvent Description
Friday, December 2, 2016APPLICATION FILING RECEIPT MAILED
Thursday, December 8, 2016NON-FINAL ACTION WRITTEN
Thursday, November 24, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, November 28, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 7, 2016ASSIGNED TO EXAMINER
Tuesday, May 2, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 3, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 5, 2017NON-FINAL ACTION WRITTEN
Friday, May 5, 2017NON-FINAL ACTION E-MAILED
Friday, May 5, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 6, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 9, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, December 10, 2016REFUSAL PROCESSED BY MPU
Saturday, December 10, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, December 30, 2016REFUSAL PROCESSED BY IB
Tuesday, April 4, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 2, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 6, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 7, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 22, 2017FINAL REFUSAL WRITTEN
Wednesday, November 22, 2017FINAL REFUSAL E-MAILED
Wednesday, November 22, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, April 25, 2018NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, May 11, 2018NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, April 25, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, May 22, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, May 22, 2018EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, May 22, 2018JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, May 22, 2018EX PARTE APPEAL-INSTITUTED
Thursday, May 31, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 31, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 4, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 4, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 29, 2018ASSIGNED TO LIE
Thursday, June 14, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 24, 2018PUBLISHED FOR OPPOSITION
Tuesday, July 24, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, August 23, 2018ASSIGNED TO EXAMINER
Tuesday, October 9, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, October 10, 2018EXPARTE APPEAL TERMINATED
Wednesday, January 9, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, January 23, 2019FINAL DISPOSITION PROCESSED
Wednesday, July 4, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, September 13, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, October 6, 2018NOTIFICATION PROCESSED BY IB
Monday, October 9, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, April 25, 2025CANCELLED SECTION 71
Friday, February 8, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, January 23, 2019FINAL DISPOSITION NOTICE SENT TO IB

Related Keywords

inviapi medical research scientific field pharmaceuticals trials information clinical oncology fields